Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Tolcapone on Frontotemporal Dementia
This study is ongoing, but not recruiting participants.
Study NCT00604591   Information provided by National Institutes of Health Clinical Center (CC)
First Received: January 19, 2008   Last Updated: March 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Frontotemporal Lobar Degeneration
Additional conditions recognized in this trial
Aphasia, Primary Progressive
Dementia
Pick Disease of the Brain
More general conditions related to this trial
Aphasia
Brain Diseases
Central Nervous System Diseases
Communication Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Language Disorders
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Speech Disorders
Interventions listed in this trial
Tolcapone
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services